NEW YORK (GenomeWeb News) – Illumina has filed a lawsuit against DNAPrint Genomics and its Ellipsis Biotherapeutics subsidiary seeking payment for products Illumina shipped to the firm in 2007-2008.
According to the suit, which was filed last week in the US District Court for the Southern District of California, Illumina is seeking nearly $275,000 in payments from DNAPrint Genomics for genotyping kits and DNA analysis kits that it ordered from Illumina and didn't pay for, as stipulated under a contract between the firms in April 2007.
As reported by GenomeWeb Daily News two weeks ago, DNAPrint Genomics shut down its operations sometime in February or early March.
Between December 2006 and June 2008, DNAPrint entered into nine separate purchase order contracts with Illumina. The suit alleges that although Illumina provided all of the products under the agreements, DNAPrint never made payments on the products.
Illumina has demanded a jury trial seeking payment of the full amount due, plus interest and the award of attorneys' fees.